UK markets closed

Gaxos.ai Inc. (GXAI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.93000.0000 (0.00%)
At close: 04:00PM EDT
3.8300 -0.10 (-2.54%)
After hours: 06:58PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.9300
Open3.9192
Bid0.0000 x 0
Ask0.0000 x 0
Day's range3.8400 - 3.9499
52-week range2.1720 - 19.2000
Volume12,705
Avg. volume854,112
Market cap4.298M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Gaxos Health Expands Medical Advisory Board

    Roseland, NJ, April 25, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. ("Gaxos" or the "Company"), a company developing artificial intelligence applications across various sectors, today announced that Gaxos Health has expanded its Medical Advisory Board with the appointment of Dr. Eric Margolis and Dr. Jeff Pavell. “The addition of top medical talent to our Medical Advisory Board reflects our continued commitment to pursuing a best-in-class solution for Gaxos Health,” said Vadim Mats, CEO of Gaxos.AI.

  • GlobeNewswire

    Gaxos.ai Regains Compliance with Nasdaq Listing Requirements

    Roseland, NJ, March 26, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it received written notice from the NASDAQ Stock Market LLC (NASDAQ) on March 22, 2024, informing the Company that it has regained compliance with the minimum bid price requirement under NASDAQ Listing Rule 5550(a)(2) for continued listing on the NASDAQ Capital Market. On July 10, 2023, NA

  • GlobeNewswire

    Gaxos.ai Inc. Announces Closing of $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules

    Roseland, NJ, March 15, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, announced today that it has closed its previously announced private placement for the purchase and sale of 628,367 shares of common stock (or pre-funded warrant in lieu thereof), series A warrants to purchase up to 628,367 shares of common stock and short-term series B warrants to purchase up to 628,367 shares